- Home
- GRWG vs IVA Comparison
GRWG vs IVA Comparison
Compare GRWG & IVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRWG
- IVA
- Stock Information
- Founded
- GRWG 2008
- IVA 2011
- Country
- GRWG United States
- IVA France
- Employees
- GRWG N/A
- IVA N/A
- Industry
- GRWG RETAIL: Building Materials
- IVA Biotechnology: Pharmaceutical Preparations
- Sector
- GRWG Consumer Discretionary
- IVA Health Care
- Exchange
- GRWG Nasdaq
- IVA Nasdaq
- Market Cap
- GRWG 121.3M
- IVA 117.3M
- IPO Year
- GRWG N/A
- IVA 2020
- Fundamental
- Price
- GRWG $2.01
- IVA $2.53
- Analyst Decision
- GRWG Hold
- IVA Strong Buy
- Analyst Count
- GRWG 5
- IVA 3
- Target Price
- GRWG $2.75
- IVA $18.00
- AVG Volume (30 Days)
- GRWG 431.8K
- IVA 14.4K
- Earning Date
- GRWG 11-06-2024
- IVA 09-25-2024
- Dividend Yield
- GRWG N/A
- IVA N/A
- EPS Growth
- GRWG N/A
- IVA N/A
- EPS
- GRWG N/A
- IVA N/A
- Revenue
- GRWG $206,554,000.00
- IVA $20,652,523.00
- Revenue This Year
- GRWG N/A
- IVA N/A
- Revenue Next Year
- GRWG N/A
- IVA $469.85
- P/E Ratio
- GRWG N/A
- IVA N/A
- Revenue Growth
- GRWG N/A
- IVA N/A
- 52 Week Low
- GRWG $1.77
- IVA $1.53
- 52 Week High
- GRWG $3.38
- IVA $4.75
- Technical
- Relative Strength Index (RSI)
- GRWG 47.76
- IVA 71.26
- Support Level
- GRWG $1.95
- IVA $1.60
- Resistance Level
- GRWG $2.18
- IVA $1.92
- Average True Range (ATR)
- GRWG 0.10
- IVA 0.15
- MACD
- GRWG -0.00
- IVA 0.06
- Stochastic Oscillator
- GRWG 27.72
- IVA 96.10
About GRWG GrowGeneration Corp.
GrowGeneration Corp owns and operates specialty retail hydroponic and organic gardening stores. The firm is a marketer and distributor of nutrients, growing media, advanced indoor and greenhouse lighting, ventilation systems and accessories for hydroponic gardening. The Company has two reportable segments, including Cultivation and Gardening segment, composed of the Company's hydroponic and organic gardening business; and the Storage Solutions segment, composed of the Company's benching, racking, and storage solutions business.
About IVA Inventiva S.A. American Depository Shares
Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.